SOCS1 and laryngeal carcinoma: Suppressor of cytokine signaling 1 (SOCS1), a regulator of cytokine-mediated innate and adaptive immunity, has been reported to inhibit the TLR4–NF-κB pathway in laryngeal carcinoma.